Orazipone, a locally acting immunomodulator, ameliorates intestinal radiation injury: A preclinical study in a novel rat model

International Journal of Radiation Oncology Biology Physics

Volumn 66, Issue 2, 2006, Pages 552-559

  Boerma, Marjan ^a   Wang, Junru ^a   Richter, Konrad K ^a   Hauer Jensen, Martin ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

Disaster planning; Immunomodulation; Intestines; Radiation injuries

Indexed keywords

BIOLOGICAL ORGANS; DOSIMETRY; HISTOLOGY; IMMUNOLOGY; ONCOLOGY; RADIOTHERAPY;

DISASTER PLANNING; IMMUNOMODULATION; INTESTINES; RADIATION INJURIES;

MEDICAL PROBLEMS;

3 [[4 (METHYLSULFONYL)PHENYL]METHYLENE] 2,4 PENTADIONE; DRUG VEHICLE; IMMUNOMODULATING AGENT; ORAZIPONE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RADIOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; END TO SIDE ANASTOMOSIS; GASTROINTESTINAL TOXICITY; HISTOPATHOLOGY; ILEOSTOMY; IMMUNOMODULATION; IMMUNOREACTIVITY; INTESTINE INJURY; INTESTINE MUCOSA; INTESTINE WALL; LOCAL THERAPY; MALE; MAST CELL; NONHUMAN; ORCHIECTOMY; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION ENTEROPATHY; RADIATION INJURY; RAT; SINGLE DRUG DOSE; TERRORISM; X IRRADIATION;

ANIMALS; ILEOSTOMY; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; MODELS, ANIMAL; ORCHIECTOMY; RADIATION INJURIES, EXPERIMENTAL; RADIATION TOLERANCE; RADIATION-PROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; SULFHYDRYL COMPOUNDS; TRANSFORMING GROWTH FACTOR BETA;

EID: 33748331265     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.05.067     Document Type: Article

References (34)

1. Sonis S.T., Elting L.S., Keefe D., et al. Perspectives on cancer therapy-induced mucosal injury: Pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100 (2004) 1995-2025
2. Andreyev J. Gastrointestinal complications of pelvic radiotherapy: Are they of any importance?. Gut 54 (2005) 1051-1054
3. Hauer-Jensen M., Wang J., and Denham J.W. Bowel injury: Current and evolving management strategies. Semin Radiat Oncol 13 (2003) 357-371
4. Denham J.W., and Hauer-Jensen M. The radiotherapeutic injury-A complex "wound.". Radiother Oncol 63 (2002) 129-145
5. Nissinen E., Serkkola E., Pentillä K.E., et al. Suppression of cytokine production and neutrophil activation by an immunomodulating agent OR-1384 [Abstract]. Annual Meeting of American Gastroenterological Association (1997) May 10-16
6. Murthy S., Murthy N.S., Coppola D., et al. A novel immunomodulating agent (OR-1384) ameliorates inflammation and tissue damage in dextran sulfate model of mouse colitis [Abstract]. Annual Meeting of American Gastroenterological Association (1997) May 10-16
7. Aho P., Koponen A., Haasio K., et al. OR-1384, a novel locally acting immunomodulating agent, protects against experimental colitis [Abstract]. Annual Meeting of American Gastroenterological Association (1997) May 10-16
8. Nissinen E., Kaivola J., and Linden I.B. Interleukin-8 induced neutrophil activation is suppressed by the thiol modulating anti-colitis agent OR-1384 [Abstract]. Annual Meeting of American Gastroenterological Association (1996) May 18-24
9. Hauer-Jensen M. Late radiation injury of the small intestine. Clinical, pathophysiologic, and radiobiologic aspects. Acta Oncol 29 (1990) 401-415
10. Hauer-Jensen M., Poulakos L., and Osborne J.W. Effects of accelerated fractionation on radiation injury of the small intestine: A new rat model. Int J Radiat Oncol Biol Phys 14 (1988) 1205-1212
11. Hauer-Jensen M., Sauer T., Devik F., et al. Late changes following single dose roentgen irradiation of rat small intestine. Acta Radiol Oncol 22 (1983) 299-303
12. Langberg C.W., Sauer T., Reitan J.B., et al. Tolerance of rat small intestine to localized single dose and fractionated irradiation. Acta Oncol 31 (1992) 781-787
13. Baddeley A.J., Gundersen H.J.G., and Cruz-Orive L.M. Estimation of surface area from vertical sections. J Microsc 142 (1986) 259-276
14. Langberg C.W., Sauer T., Reitan J.B., et al. Relationship between intestinal fibrosis and histopathologic and morphometric changes in consequential and late radiation enteropathy. Acta Oncol 35 (1996) 81-87
15. Richter K.K., Langberg C.W., Sung C.C., et al. Increased transforming growth factor beta (TGF-beta) immunoreactivity is independently associated with chronic injury in both consequential and primary radiation enteropathy. Int J Radiat Oncol Biol Phys 39 (1997) 187-195
16. Wang J., Zheng H., Sung C.C., et al. Cellular sources of transforming growth factor-beta isoforms in early and chronic radiation enteropathy. Am J Pathol 153 (1998) 1531-1540
17. Zheng H., Wang J., Koteliansky V.E., et al. Recombinant soluble transforming growth factor beta type II receptor ameliorates radiation enteropathy in mice. Gastroenterology 119 (2000) 1286-1296
18. Vigneulle R.M., Herrera J., Gage T., et al. Nonuniform irradiation of the canine intestine. I. Effects. Radiat Res 121 (1990) 46-53
19. Hashimoto N., Ohyanagi H., and Kazuyuki S. Effect of glicentin on gut mucosal growth in rats with jejunal and ileal Thiry-Vella fistulas. J Pediatr Surg 38 (2003) 579-584
20. Vendelin J., Laitinen C., Vainio P.J., et al. Novel sulfhydryl-reactive compounds orazipone and OR-1958 inhibit cytokine production and histamine release in rat and human mast cells. Int Immunopharmacol 5 (2005) 177-184
21. Linden I.B., Aho P., Nissinen E., et al. Protection in acute and chronic colitis models by the sulhydryl modulating compound OR-1364 [Abstract]. American Gastroenterological Association (1992) May 9-15
22. Aho P., Koponen A., Haasio K., et al. Protection against immune complex-induced colitis in rabbits by OR-1364 [Abstract]. United European Gastroenterology Week (1994) June 25-29
23. Aho P., Nissinen E., Penttila K.E., et al. The sulhydryl modulating compound OR-1364 protects against free radical induced colitis in rats [Abstract]. American Gastroenterological Association (1993) May 15-19
24. Ferreira R.C., Forsyth L.E., Richman P.I., et al. Changes in the rate of crypt epithelial cell proliferation and mucosal morphology induced by a T-cell-mediated response in human small intestine. Gastroenterology 98 (1990) 1255-1263
25. Wu G., Fang Y.Z., Yang S., et al. Glutathione metabolism and its implications for health. J Nutr 134 (2004) 489-492
26. Zheng H., Wang J., and Hauer-Jensen M. Role of mast cells in early and delayed radiation injury in rat intestine. Radiat Res 153 (2000) 533-539
27. Wang J., Zheng H., Sung C.C., et al. Cellular sources of transforming growth factor-beta isoforms in early and chronic radiation enteropathy. Am J Pathol 153 (1998) 1531-1540
28. Canney P.A., and Dean S. Transforming growth factor beta: A promoter of late connective tissue injury following radiotherapy?. Br J Radiol 63 (1990) 620-623
29. Zheng H., Wang J., Koteliansky V.E., et al. Recombinant soluble transforming growth factor beta type II receptor ameliorates radiation enteropathy in mice. Gastroenterology 119 (2000) 1286-1296
30. Rodemann H.P., and Bamberg M. Cellular basis of radiation-induced fibrosis. Radiother Oncol 35 (1995) 83-90
31. Danese S., Scaldaferri F., Papa A., et al. Platelets: New players in the mucosal scenario of inflammatory bowel disease. Eur Rev Med Pharmacol Sci 8 (2004) 193-198
32. Verheij M., Dewit L.G.H., Boomgard M.N., et al. Ionizing radiation enhances platelet adhesion to the extracellular matrix of human endothelial cells by an increase in the release of von Willebrand factor. Radiat Res 137 (1994) 202-207
33. te Poele J.A.M., van Kleef E.M., van der Wal A., et al. Radiation-induced glomerular thrombus formation and nephropathy are not prevented by the ADP receptor antagonist clopidogrel. Int J Radiat Oncol Biol Phys 50 (2001) 1332-1338
34. Wang J., Albertson C.M., Zheng H., et al. Short-term inhibition of ADP-induced platelet aggregation by clopidogrel ameliorates radiation-induced toxicity in rat small intestine. Thromb Haemost 87 (2002) 122-128